Board meetings, strategic plans, and buyer signals from Julia Colecchi’s organization
Jun 2, 2026·BoardMeeting
Board
Northeast Ohio Medical University Board of Trustees Meeting Agenda
The Board of Trustees discussed various institutional reports including progress on fiscal year goals, academic actions, and research programs. Key approvals included non-tenure track faculty appointments and promotions, curriculum ratifications, the campus completion plan, and an award for a distinguished university professor. Financial actions encompassed the approval of tuition and fees, the operating budget, capital expenditures for campus improvements, and updates to the investment policy statement. The board also addressed personnel actions and approved a resolution of appreciation for a departing member.
Enterprise
Get verified public-sector contacts at scale
Find verified emails, direct dials, role context, job-change updates, and organization signals across every public-sector account you sell to.
The board discussed several items, including a report from the Institutional Advancement Committee regarding FY26 fundraising priorities and initiatives. The Evaluation and Compensation Committee reviewed options for the President's compensation package, while the Academic and Scientific Affairs Committee addressed faculty appointments, curricular approval processes, and honorary degrees. The Finance, Fiscal Policy and Investment Committee reviewed personnel appointments, student fees, and capital expenditures for library renovations. Additionally, the President provided updates on student academic milestones, upcoming events, the launch of an employee engagement initiative, and strategic growth. A strategic plan update was presented, highlighting achievements in enrollment, research participation, and institutional performance metrics.
Feb 17, 2026·BoardMeeting
Board
Neomed Campus Update
The February update focused on recognizing faculty and staff achievements, including external research funding secured by multiple faculty members, such as Dr. Sam Krish, Dr. Phil Turk, Dr. Jen Reneker, Dr. Basson, Dr. Christine Kish, and Dr. Matt Smith. Total recent funding since the last update exceeded $1.5 million, with major awards for Dr. Ramen and Dr. Lose. Dr. Sarah Dugan was recognized for her nomination as a Fellow for the American Association of Psychiatric Pharmacists. A significant segment detailed the conclusion of year four of the 'ideiator' joint venture with University Hospitals, which addresses major healthcare problems through interdisciplinary teams focused this year on environmental health, following previous years on maternal health, gun violence, and food insecurity. Recognition was given to Subie Simmons for joining the United States Navy. The establishment of the $1.5 million endowed Igel Family Award for high-impact research in the College of Medicine was announced. Chief Callie Williams was congratulated for completing the Certified Law Enforcement Executive Program. Preparations for an active threat training exercise on March 17th were announced. Updates were also provided on the thriving Vitals program, the upcoming Escapius Ball on March 27th with a 'Starry Night' theme, and employee recognition in March. Finally, an overview of the Net Promoter Score (NPS) methodology was presented in preparation for sharing results from faculty and staff surveys.
Feb 5, 2026·StrategicPlan
Board
Harrington Discovery Institute and Oxford Harrington Rare Disease Center Vision
The presentation details the mission and strategy of the Harrington Discovery Institute and Oxford Harrington Rare Disease Center to accelerate cures for rare diseases. The core approach involves a 'nonprofit pharma' model that identifies and supports breakthrough projects globally. Key focus areas include providing drug development expertise, fostering partnerships across academia, industry, and philanthropy, and leveraging genomic data and gene-targeted therapeutics. The vision aims to translate biomedical discoveries into new medicines, addressing significant unmet medical needs in various disease categories such as neurological, metabolic, and oncology disorders.
Extracted from official board minutes, strategic plans, and video transcripts.
